82137-52-8

Upstream product

• 3587-60-8 Benzyloxymethyl chloride 
• 6974-32-9 1-O-acetyl-2,3,5-tri-O-benzoyl-β-D-ribofuranose 
• 82137-50-6 5-<(benzyloxy)methyl>-1,5-dihydro-4H-imidazo<4,5-d>pyridazin-4-one 
• 92574-77-1 4-amino-5-nitro-2-benzyloxymethylpyridazin-3-one 
• 92574-76-0 4-hydroxy-5-nitro-2-benzyloxymethylpyridazin-3-one 
• 92574-75-9 2-((benzyloxy)methyl)-4,5-dichloropyridazin-3(2H)-one 
• 92574-78-2 4,5-diamino-2-benzyloxymethyl-2H-pyridazine-3-one 
• 82137-50-6 5-Benzyloxymethylimidazo<4,5-d>pyridazin-4(5H)-one 
• 82151-43-7 3-(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)-5-benzyloxymethylimidazo<4,5-d>pyridazin-4-one 

Downstream Products

• 82137-55-1 1-(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)imidazo<4,5-d>pyridazin-4-(5H)-one 
• 75909-15-8 adenosine 
• 92574-79-3 1-(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)imidazo<4,5-d>pyridazin-4(5H)-thione 

Relevant academic research and scientific papers

Purine nucleoside analogues for treating flaviviridae including hepatitis C

This invention is directed to a method for treating a host, especially a human, infected with hepatitis C, flavivirus and/or pestivirus, comprising administering to that host an effective amount of an anti-HCV biologically active pentofuranonucleoside whe